“Can biotechnology and genetic engineering turn the clock back for a generation of boomers? A land rush of advanced research and investment into the biology of aging is yield- ing tantalizing prospects.”

That’s the opening paragraph of a fascinating new article, “New Aging Research Yields Tantalizing Prospects,” written by Craig Ladkin, a FOCUS Investment Banking Managing Director and a member of the FOCUS Healthcare and Life Science team, in conjunction with Bo Varga, a technology advisor to early stage companies, who is data-driven and focused on understanding the science and technology that leads to commercial products and services.

Oops! We could not locate your form.